David D. Davidar is Director at GLOBUS MEDICAL INC (GMED). They have made 12 open-market trades across 1 company since 2012, most recently 2026-07-27.
CIK 0001555268
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GMED | 507,675 | $44.2M |
Shares reported on the most recent Form 4, priced at the 2026-07-28 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GMED | SELL | 2026-06-05 | 2026-06-09 | $80.76 | $2.0M | -3.6% | -6.6% | -8.6% |
| GMED | SELL | 2025-11-12 | 2025-11-13 | $86.00 | $2.1M | +10.5% | +4.8% | +6.9% |
| GMED | SELL · 10b5-1 | 2024-11-21 | 2024-11-25 | $85.00 | $3.4M | -1.9% | -0.6% | -5.8% |
| GMED | SELL · 10b5-1 | 2024-10-16 | 2024-10-18 | $75.04 | $3.8M | +3.0% | +12.3% | +24.2% |
| GMED | SELL | 2024-09-13 | 2024-09-17 | $70.46 | $3.5M | +2.3% | +7.1% | +18.4% |
| GMED | SELL · 10b5-1 | 2024-05-08 | 2024-05-10 | $65.00 | $1.3M | +3.8% | +2.3% | +14.3% |
| GMED | SELL | 2022-04-19 | 2022-04-21 | $78.03 | $2.5M | -5.2% | -5.7% | -17.1% |
| GMED | SELL | 2020-11-24 | 2020-11-27 | $60.00 | $2.5M | -0.5% | +8.7% | +3.3% |
| GMED | SELL | 2019-11-07 | 2019-11-12 | $54.01 | $2.6M | -0.0% | +5.0% | -1.0% |
| GMED | SELL | 2019-08-16 | 2019-08-19 | $49.33 | $2.5M | +2.5% | +1.8% | +9.7% |
| GMED | SELL | 2018-03-08 | 2018-03-12 | $50.50 | $3.5M | -3.4% | -2.1% | +9.0% |
| GMED | SELL | 2018-03-08 | 2018-03-12 | $50.50 | $3.5M | -3.4% | -2.1% | +9.0% |
| GMED | SELL | 2017-12-04 | 2017-12-06 | $40.66 | $751K | -0.8% | +12.4% | +27.3% |
| GMED | SELL | 2017-12-04 | 2017-12-06 | $40.66 | $1.5M | -0.8% | +12.4% | +27.3% |
| GMED | SELL · 10b5-1 | 2014-10-31 | 2014-11-04 | $23.06 | $888K | -7.9% | -2.9% | -2.9% |
| GMED | SELL · 10b5-1 | 2014-03-04 | 2014-03-06 | $25.00 | $1.9M | -7.9% | -2.9% | -2.9% |
| GMED | SELL · 10b5-1 | 2014-02-18 | 2014-02-20 | $24.00 | $1.8M | -7.9% | -2.9% | -2.9% |
| GMED | SELL · 10b5-1 | 2013-12-03 | 2013-12-05 | $19.25 | $1.4M | -7.9% | -2.9% | -2.9% |
| GMED | SELL · 10b5-1 | 2013-10-31 | 2013-11-04 | $18.20 | $1.3M | -7.9% | -2.9% | -2.9% |
| GMED | SELL · 10b5-1 | 2013-08-22 | 2013-08-26 | $18.20 | $132K | -7.9% | -2.9% | -2.9% |
| GMED | SELL · 10b5-1 | 2013-07-05 | 2013-07-08 | $17.15 | $172K | -7.9% | -2.9% | -2.9% |
| GMED | SELL · 10b5-1 | 2013-07-01 | 2013-07-03 | $16.56 | $331K | -7.9% | -2.9% | -2.9% |
| GMED | SELL · 10b5-1 | 2013-06-25 | 2013-06-27 | $16.71 | $2.5M | -7.9% | -2.9% | -2.9% |
| GMED | SELL | 2012-08-08 | 2012-08-10 | $11.16 | $1.9M | -7.9% | -2.9% | -2.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.